Biopharmaceutical company
Proposed repeal of the CMS Rule on Most Favored Nation Model;

PL-117-71 Protecting Medicare and American Families from Sequester Cuts Act - specifically:  6 months relief from 2% Medicare sequester, 4% statutory Pay-As-You-Go Act, 1 year relief of physician conversion factor cuts, 1 year delay of clinical lab (PAMA) cuts, delay of radiation oncology demo Value of prescription drugs; 

Issues related to Medicare Part D; 

Issues related to Medicare Part B; 

Implementation of American Rescue Plan Act of 2021 (PL 117-2); 

Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260); 

Monitor drug pricing legislation, including H.R. 3, Elijah E. Cummings Lower Drug Costs Now; Prescription Drug Pricing Reduction Act;

Senate Finance Committee Prescription Drug Reform Principles;
 
Education around innovative therapies in dermatology; 

H.R. 5376, Build Back Better Act; 

Monitor possible health care policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform;

PL 117-58 - Infrastructure Investment and Jobs Act (BIF) - issues related to rebate rule delay, repurposed Provider Relief Funds, Medicare savings from single source vial size drug policy and extension of mandatory sequester)
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
TRACY SPICER ELIZABETH MACDONALD BARNETT TRACY SPICER ELIZABETH MACDONALD BARNETT